Literature DB >> 24135452

Nitensidine A, a guanidine alkaloid from Pterogyne nitens, is a novel substrate for human ABC transporter ABCB1.

Yasuhiro Tajima1, Hiroshi Nakagawa2, Ai Tamura3, Onat Kadioglu4, Kazuhiro Satake1, Yuji Mitani1, Hayato Murase1, Luis Octavio Regasini5, Vanderlan da Silva Bolzani5, Toshihisa Ishikawa6, Gert Fricker7, Thomas Efferth8.   

Abstract

The Pterogyne nitens (Fabaceae) tree, native to South America, has been found to produce guanidine alkaloids as well as bioactive flavonols such as kaempferol, quercetin, and rutin. In the present study, we examined the possibility of interaction between human ATP-binding cassette (ABC) transporter ABCB1 and four guanidine alkaloids isolated from P. nitens (i.e., galegine, nitensidine A, pterogynidine, and pterogynine) using human T cell lymphoblast-like leukemia cell line CCRF-CEM and its multi-drug resistant (MDR) counterpart CEM/ADR5000. In XTT assays, CEM/ADR5000 cells were resistant to the four guanidine alkaloids compared to CCRF-CEM cells, although the four guanidine alkaloids exhibited some level of cytotoxicity against both CCRF-CEM and CEM/ADR5000 cells. In ATPase assays, three of the four guanidine alkaloids were found to stimulate the ATPase activity of ABCB1. Notably, nitensidine A was clearly found to stimulate the ATPase activity of ABCB1 as strongly as the control drug, verapamil. Furthermore, the cytotoxic effect of nitensidine A on CEM/ADR5000 cells was synergistically enhanced by verapamil. Nitensidine A inhibited the extrusion of calcein by ABCB1. In the present study, the possibility of interaction between ABCB1 and two synthetic nitensidine A analogs (nitensidine AT and AU) were examined to gain insight into the mechanism by which nitensidine A stimulates the ATPase activity of ABCB1. The ABCB1-dependent ATPase activity stimulated by nitensidine A was greatly reduced by substituting sulfur (S) or oxygen (O) for the imino nitrogen atom (N) in nitensidine A. Molecular docking studies on human ABCB1 showed that, guanidine alkaloids from P. nitens dock to the same binding pocket as verapamil. Nitensidine A and its analogs exhibit similar binding energies to verapamil. Taken together, this research clearly indicates that nitensidine A is a novel substrate for ABCB1. The present results also suggest that the number, binding site, and polymerization degree of the isoprenyl moiety in the guanidine alkaloids and the imino nitrogen atom cooperatively contribute to their stimulation of ABCB1's ATPase activity.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  ABCB1; ATP-binding cassette (ABC) transporter; Guanidine alkaloid; P-glycoprotein; Pterogyne nitens

Mesh:

Substances:

Year:  2013        PMID: 24135452     DOI: 10.1016/j.phymed.2013.08.024

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  10 in total

1.  Resistance mechanisms of cancer cells to the novel vacuolar H(+)-ATPase inhibitor archazolid B.

Authors:  Rebecca Hamm; Yoshikazu Sugimoto; Heinrich Steinmetz; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-07-29       Impact factor: 3.850

Review 2.  The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein--a well-known, yet poorly understood drug transporter.

Authors:  Maen Zeino; Mohamed E M Saeed; Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-04-22       Impact factor: 3.850

3.  Selective inhibition of P-gp transporter by goniothalamin derivatives sensitizes resistant cancer cells to chemotherapy.

Authors:  Julia Sachs; Onat Kadioglu; Anja Weber; Vanessa Mundorf; Janina Betz; Thomas Efferth; Jörg Pietruszka; Nicole Teusch
Journal:  J Nat Med       Date:  2018-07-31       Impact factor: 2.343

4.  SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines.

Authors:  Chung-Pu Wu; Megumi Murakami; Sung-Han Hsiao; Te-Chun Liu; Ni Yeh; Yan-Qing Li; Tai-Ho Hung; Yu-Shan Wu; Suresh V Ambudkar
Journal:  Cancer Lett       Date:  2018-07-06       Impact factor: 8.679

5.  Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues.

Authors:  Mohamed E M Saeed; Joelle C Boulos; Kevin Machel; Nasim Andabili; Thamail Marouni; Wilfried Roth; Thomas Efferth
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

6.  The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines.

Authors:  Sung-Han Hsiao; Megumi Murakami; Ni Yeh; Yan-Qing Li; Tai-Ho Hung; Yu-Shan Wu; Suresh V Ambudkar; Chung-Pu Wu
Journal:  Cancer Lett       Date:  2018-07-18       Impact factor: 8.679

7.  Mode of Action Analyses of Neferine, a Bisbenzylisoquinoline Alkaloid of Lotus (Nelumbo nucifera) against Multidrug-Resistant Tumor Cells.

Authors:  Onat Kadioglu; Betty Y K Law; Simon W F Mok; Su-Wei Xu; Thomas Efferth; Vincent K W Wong
Journal:  Front Pharmacol       Date:  2017-05-05       Impact factor: 5.810

8.  Identification of Novel Rare ABCC1 Transporter Mutations in Tumor Biopsies of Cancer Patients.

Authors:  Onat Kadioglu; Mohamed Saeed; Markus Munder; Andreas Spuller; Henry Johannes Greten; Thomas Efferth
Journal:  Cells       Date:  2020-01-26       Impact factor: 6.600

9.  The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors.

Authors:  Jason Goebel; Jean Chmielewski; Christine A Hrycyna
Journal:  Cancer Drug Resist       Date:  2021-08-04

10.  Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds.

Authors:  Lisa Gruber; Sara Abdelfatah; Tony Fröhlich; Christoph Reiter; Volker Klein; Svetlana B Tsogoeva; Thomas Efferth
Journal:  Molecules       Date:  2018-04-06       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.